Navigation Links
Profil Institute's Dr. Marcus Hompesch Named Finalist in Ernst & Young Entrepreneur Of The Year(R) 2010 Award for Second Year in a Row
Date:5/12/2010

SAN DIEGO, May 12 /PRNewswire/ -- Profil™ Institute for Clinical Research, Inc. (PICR) today announced that president and CEO Dr. Marcus Hompesch is a finalist for the Ernst & Young Entrepreneur Of The Year® 2010 Award in San Diego for the second year in a row. Award winners will be announced at a gala event on June 9, 2010 at the Hyatt La Jolla Aventine.

Dr. Hompesch is being recognized for his establishment and leadership of PICR, headquartered in Chula Vista, Calif.  PICR has emerged as an industry leader in performing phase I and II clinical trials for pharmaceutical companies by honing their clinical expertise and specifically focusing on new treatments for diabetes and obesity.  

Under Dr. Hompesch's leadership, the team at PICR has conducted more than 120 clinical studies investigating new drugs and devices since the company began operations in 2004 and has been involved with almost every clinically promising drug and device development in the diabetes arena.

"I am honored to have been selected as a finalist for this prestigious award for a second year in a row," said Dr. Hompesch. "It is not only personally rewarding to be recognized with these highly respected entrepreneurs, but is, in fact, a wonderful testament to what our team at PICR has been able to accomplish."

Dr. Hompesch is one of three finalists in the Health Sciences category for the San Diego regional awards ceremony. The other finalists in this category are Jonathan Lim, President and CEO of Halozyme Therapeutics, and Scott Huennekens, President and CEO of Volcano Corporation. Past years' winners include Alex V. Lukianov of NuVasive, Inc. in 2009, Jay Flatley of Illumnia, Inc. in 2008 and Tina Nova of Genoptix, Inc. in 2007.

Now entering its 24th year, the Ernst & Young Entrepreneur of The Year awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities.

Regional award winners will be eligible for consideration in the Ernst & Young Entrepreneur of The Year national program. Winners in a number of national categories, as well as the overall national Ernst & Young Entrepreneur of The Year award winner, will be announced at the annual awards gala in Palm Springs, California in November.

About Profil™ Institute for Clinical Research, Inc.

PICR is a privately held institute providing high quality early phase clinical research services in diabetes and obesity. PICR uses its expertise to guide the developmental planning, design and actual performance of early phase clinical studies that help in the determination of whether a new compound should be carried forward into the later phases of clinical development. In order to make reliable and solid development decisions based on the most accurate data, PICR utilizes specific research methods, including the automated glucose clamp procedure, which is accepted as the gold standard for pharmacodynamic data. The company's key scientists hail from academic centers including the WHO Collaborating Center of Diabetes at the Heinrich-Heine University of Dusseldorf, Columbia University, University of Michigan and Harvard University.

For more information visit www.profil-research.com

For more information on Ernst & Young's Entrepreneur Of The Year® awards program, please visit www.ey.com/us/eoy


'/>"/>
SOURCE Profil Institute for Clinical Research, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BellBrook Labs Launches Compound Profiling Services with High Content 3D Invasion Assay
2. New Study Demonstrates Patients With High-Risk MammaPrint Profile Benefit From Chemotherapy
3. Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project
4. Atherotechs Advanced Lipid Profile Featured in Lipoprotein and Epidemiology Research at ACC 2010
5. Reportlinker Adds the Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
6. Nanometer Online Inspection With Nanovea 3D Non-Contact Profilometer
7. WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System
8. NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database
9. Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration
10. Sigma-Aldrich Introduces Precisio(TM) Kinases for High-Throughput Screening and Kinase Profiling
11. Metametrix Introduces the New TRIAD(SM) Bloodspot Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016  Allergan plc (NYSE: ... announced that Brent Saunders , Allergan,s CEO and ... a fireside chat session at the RBC Capital Markets ... p.m. ET at The New York Palace Hotel in ... will be webcast live and can be accessed on ...
(Date:2/10/2016)... ... 10, 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics will feature ... in San Francisco’s Moscone Center from February 16-18, 2016, and at the healthcare-focused ... latest InGaAs PIN diode standard packages feature a TO-46 metal can with active areas ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... medicine, has announced a new agreement with Singapore-based Global Stem Cells Network (GSCN) ... the Philippines, Thailand and Singapore in the latest adipose and bone marrow therapies. ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
Breaking Biology News(10 mins):